Aceglatone

This classification denotes a glucuronidase inhibitor with the molecular formula C10H10O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 347Q3OOJ13, chemically known as 2,5-di-o-acetyl-d-glucosaccharo-1,4:6,3-dilactone but more generally known as aceglatone, which bears US NIH Compound Identifier 1980. European Medicines Agency schedules Aceglatone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05207MIG. The term ACEGLATONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). ACEGLATONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, ACEGLATONE remains US FDA's Preferred Term for this commodity. Aceglatone bears US NLM identifiers UMLS ID C0050406 and NCI Concept Code C984. SMILES: CC(=O)OC1C2C(C(C(=O)O2)OC(=O)C)OC1=O.